Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1994-11-17
1997-03-25
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514249, A61K 3156, A61K 31495
Patent
active
056145152
ABSTRACT:
Compositions and method for the minimization or prevention of adhesion formation, whereby an effective amount of at least one lazaroid compound, preferably one of general formula I, is administered for a period of time sufficient to permit tissue repair. The compound of general formulae I or II is preferably administered in conjunction with a delivery vehicle (e.g., microcapsules, microspheres, biodegradable polymer films, lipid-based delivery systems such as liposomes and lipid foams, viscous instillates and absorbable mechanical barriers) useful for maintaining local concentrations of the compound at an effective level.
REFERENCES:
patent: 4937254 (1990-06-01), Sheffield et al.
patent: 4968675 (1990-11-01), Su et al.
patent: 5256408 (1993-10-01), Babcock et al.
diZerega & Rodgers (1992), "Prevention of Postoperative Adhesions" in The Peritoneum, diZerega, G. S. & Rodgers K. E., ed., Springer-Verlag, New York, pp. 307-369.
Elkins, T. E. (1990), "Can a Pro-Coagulant Substance Prevent Adhesions?" in Treatment of Post-Surgical Adhesions, diZerega, G. S. et al. eds., Wiley-Liss, New York, pp. 103-112.
Rodgers, K. E. (1990), "Nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of Postsurgical adhesion," in Treatment of Post-Surgical Adhesiona, diZerega, G. S. et al., eds., Wiley-Liss, New York, pp. 119-129.
Thomas et al. (1993), Biochem. Pharmacol., vol. 45, pp. 241-251.
Braughler et al. (1987), J. Biol. Chem., vol. 262, pp. 10438-10440.
Fisher et al. (1991), Neurology, vol. 41, pp. 297-299.
Kim et al. (1992), Cancer Letters, vol. 64, pp. 61-66.
Singh and Bonin (1991), Life Sciences, vol. 49, pp. 2053-2058.
Braughler et al. (1989), Free Rad. Biol. & Med., vol. 7, pp. 125-130.
Braughler et al., (1989), Free Rad. Biol. & Med., vol. 6, pp. 289-301.
Aoki et al. (1990), J. Cardiovas. Pharm., vol. 15, pp. 205-210.
Hall et al. (1990), Stroke, vol. 21, 111-83-87.
Kim et al. (1993), Cancer Chemother. Pharmacol., vol. 33, pp. 187-190.
Chatelut et al. (1993), Cancer Chemother. Pharmacol., vol. 32, pp. 179-182.
Shappell et al. (1992), FASEB Journal, vol. 6(4), p. A1428.
Choi et al. (1993), Am. J. Pathol., vol. 142, pp. 519-528.
Rodgers et al. (1988), Int'l. J. Immunopharm., vol. 10, pp. 111-120.
Lewis, D. H. (1990), "Controlled Release of Bioactive Agents from Lactide/Glycolide Polymers," in Biodegradable Polymers as Drug Delivery Systems, Jason & Langer, ed., pp. 1-41.
Hoeckel et al. (1987), Annales Chirurgiae et Gynaecologiae, vol. 76, pp. 306-313.
Rodgers et al. (1990), Int. J. Fertil., vol. 35, p. 40.
Abe et al. (1990), J. Surg. Res., vol. 49, p. 322.
Fertility & Sterility, vol. 51, p. 933, 1989.
Diamond et al. (1991), Fertility and Sterility, vol. 55, p. 389.
Diamond et al. (1991), J. Gyn. Surg., vol. 7, p. 1.
Nishimura et al. (1984), Am. J. Med., vol. 77, pp. 102-106.
Hall, E. D. (1992), Ann. Neuro., vol. 32, pp. 137-142.
diZerega Gere S.
Rodgers Kathleen E.
Cintins Marianne M.
MacMillan Keith
University of Southern California
LandOfFree
Lazaroid-based compositions and method for preventing adhesion f does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lazaroid-based compositions and method for preventing adhesion f, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lazaroid-based compositions and method for preventing adhesion f will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2203569